To promote and protect the health of diverse populations through research and communication of regulatory science that addresses health disparities.
We aim to:
- To improve regulatory science by increasing the amount of clinical trial data available on racial and ethnic minorities; improve the data quality to determine how minorities react to medical products; and increase transparency and access to available data.
- To strengthen FDA’s ability to respond to minority health concerns.
- To promote health and safety communication to minority populations who often experience low health literacy and/or speak English as a second language.
Find more resources from the FDA Office of Minority Health.